ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
tradin'up
|
297 |
102K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
102K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
tradin'up
|
5.0K |
1.4M |
4 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
5.0K
|
1.4M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
tradin'up
|
5.0K |
1.4M |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
5.0K
|
1.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
tradin'up
|
13K |
6.3M |
12 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
13K
|
6.3M
|
12
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
tradin'up
|
13K |
6.3M |
7 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
tradin'up
|
13K |
6.3M |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
tradin'up
|
5.0K |
1.4M |
17 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
17
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Momentum Building with Cash Receipts up 112% for Q2 FY22
|
|
tradin'up
|
76 |
33K |
2 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
76
|
33K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
tradin'up
|
408 |
134K |
14 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
408
|
134K
|
14
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
tradin'up
|
408 |
134K |
15 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
408
|
134K
|
15
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
tradin'up
|
408 |
134K |
22 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
408
|
134K
|
22
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS
|
|
tradin'up
|
486 |
137K |
11 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
486
|
137K
|
11
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS
|
|
tradin'up
|
486 |
137K |
10 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
486
|
137K
|
10
|
|
ASX - By Stock
|
GTG |
Re:
CV-19 SDR IBX Test Approved
|
|
tradin'up
|
68 |
29K |
2 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
68
|
29K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
CV-19 SDR IBX Test Approved
|
|
tradin'up
|
68 |
29K |
4 |
11/09/21 |
11/09/21 |
ASX - By Stock
|
68
|
29K
|
4
|
|
ASX - By Stock
|
LGP |
Re:
Ann: LGP expands into Psychedelic Medicines
|
|
tradin'up
|
21 |
7.7K |
3 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
21
|
7.7K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
CV-19 SDR IBX Test Approved
|
|
tradin'up
|
68 |
29K |
1 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
68
|
29K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Ann: GTG COVID-19 Risk Test launched in USA
|
|
tradin'up
|
52 |
17K |
7 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
52
|
17K
|
7
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
tradin'up
|
368 |
119K |
13 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
368
|
119K
|
13
|
|
ASX - By Stock
|
BIT Biotech |
Re:
TRUMP COVID19 POSITIVE
|
|
tradin'up
|
23 |
11K |
5 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
23
|
11K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
tradin'up
|
13K |
6.3M |
1 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Genetic Technologies Announces USD 8 Million capital raising
|
|
tradin'up
|
43 |
11K |
7 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
43
|
11K
|
7
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Genetic Technologies Announces USD 8 Million capital raising
|
|
tradin'up
|
43 |
11K |
2 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
43
|
11K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Genetic Technologies Announces USD 8 Million capital raising
|
|
tradin'up
|
43 |
11K |
2 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
43
|
11K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
News: GTG Genetic Technologies Says Successful Prototype Polygenic Risk Score For Covid-19 Created
|
|
tradin'up
|
24 |
7.3K |
7 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
24
|
7.3K
|
7
|
|
ASX - By Stock
|
ALT |
Re:
News: ALT Analytica Says Coronavirus Severely Impacted Negotiations & Product Trials
|
|
tradin'up
|
33 |
10K |
0 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
33
|
10K
|
0
|
|
ASX - By Stock
|
ALT |
Re:
Telehealth
|
|
tradin'up
|
7 |
1.9K |
2 |
05/04/20 |
05/04/20 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
ALT |
Telehealth
|
|
tradin'up
|
7 |
1.9K |
5 |
29/03/20 |
29/03/20 |
ASX - By Stock
|
7
|
1.9K
|
5
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Rights Issue Offer Document
|
|
tradin'up
|
24 |
15K |
5 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
24
|
15K
|
5
|
|
ASX - By Stock
|
ALT |
Re:
Ann: PeriCoach CE Marking for Treatment of Pelvic Organ Prolapse
|
|
tradin'up
|
11 |
4.5K |
9 |
19/04/19 |
19/04/19 |
ASX - By Stock
|
11
|
4.5K
|
9
|
|
ASX - By Stock
|
GTG |
Re:
Buy order
|
|
tradin'up
|
50 |
17K |
2 |
16/01/19 |
16/01/19 |
ASX - By Stock
|
50
|
17K
|
2
|
|
ASX - By Stock
|
ALT |
Annual Report
|
|
tradin'up
|
0 |
288 |
4 |
19/10/18 |
19/10/18 |
ASX - By Stock
|
0
|
288
|
4
|
|
ASX - By Stock
|
ALT |
Re:
Ann: TGA clearnance to assist treatment of Pelvic Organ Prolapse
|
|
tradin'up
|
33 |
16K |
0 |
09/05/18 |
09/05/18 |
ASX - By Stock
|
33
|
16K
|
0
|
|
ASX - By Stock
|
ALT |
Re:
News?
|
|
tradin'up
|
12 |
6.0K |
4 |
19/04/18 |
19/04/18 |
ASX - By Stock
|
12
|
6.0K
|
4
|
|
ASX - By Stock
|
ALT |
News?
|
|
tradin'up
|
12 |
6.0K |
4 |
18/04/18 |
18/04/18 |
ASX - By Stock
|
12
|
6.0K
|
4
|
|
ASX - By Stock
|
ALT |
Re:
Auction
|
|
tradin'up
|
30 |
11K |
9 |
25/06/17 |
25/06/17 |
ASX - By Stock
|
30
|
11K
|
9
|
|
ASX - By Stock
|
ALT |
Re:
News Article
|
|
tradin'up
|
6 |
2.2K |
4 |
07/06/16 |
07/06/16 |
ASX - By Stock
|
6
|
2.2K
|
4
|
|
ASX - By Stock
|
ALT |
Re:
Ann: Pericoach case studies in peer reviewed urology journal-ALT.AX
|
|
tradin'up
|
10 |
3.7K |
4 |
02/06/16 |
02/06/16 |
ASX - By Stock
|
10
|
3.7K
|
4
|
|
ASX - By Stock
|
ALT |
Re:
Ann: Pericoach case studies in peer reviewed urology journal-ALT.AX
|
|
tradin'up
|
10 |
3.7K |
4 |
25/05/16 |
25/05/16 |
ASX - By Stock
|
10
|
3.7K
|
4
|
|